Medicaid spending on autism therapy jumped from $300 million to $2 billion in just eight states over seven years. Cato's Ryan Bourne, Jeff Singer, and Adam Omary argue the cause isn't an epidemic; it's distorted incentives and a diagnostic manual that keeps expanding.

Hosted on Acast. See acast.com/privacy for more information.